Research Timeline – MDMA

On July 27, 2016, an Institutional Review Board (IRB) approved the third protocol amendment for our ongoing Phase 1 study of the psychological effects of MDMA when taken in a therapeutic setting by healthy …

On December 6, 2013, the fourth subject began treatment in our ongoing Boulder, Colorado, study of MDMA-assisted psychotherapy for 17 subjects with chronic, treatment-resistant PTSD. This subject was enrolled …

Note: We are now subtracting dropouts from the total number of subjects treated to more accurately reflect study progress. On November 8, 2013, the 14th subject began treatment in our ongoing study of …

On October 5, 2013, the 15th subject was treated in our ongoing study of MDMA-assisted psychotherapy for U.S. veterans, firefighters, and police officers with service-related PTSD. On October 3, the U.S. …

On September 12, 2013, the 15th subject was enrolled in our ongoing study of MDMA-assisted psychotherapy for 24 U.S. veterans, firefighters, and police officers with service-related PTSD. The 14th subject …

From August 1-6, 2013, MAPS clinical research staff conducted a regularly scheduled monitoring visit at the study site for our ongoing study of MDMA-assisted psychotherapy for U.S. veterans, firefighters, …

On December 13, 2013, the U.S. Drug Enforcement Administration inspected the pharmacy where the MDMA will be stored for our upcoming study of MDMA-assisted therapy for social anxiety in autistic adults. …

On October 16, 2012, MAPS Executive Director Rick Doblin, Ph.D., and the MAPS clinical team met via teleconference with a member of the grants administration staff at the National Institute of Mental Health …